Use of apixaban in adults with congenital heart disease and atrial arrhythmias: The PROTECT-AR study

Adults with congenital heart disease (ACHD) and atrial arrhythmias (AA) face an increased risk of thromboembolic events. Limited data exist on the use of non-vitamin K oral anticoagulants for thromboprophylaxis in ACHD. We aimed to assess the effectiveness and safety of apixaban in ACHD patients with AA.

Source: International Journal of Cardiology - March 30, 2024 Category: Cardiology Authors: Anastasios Kartas, Andreas S. Papazoglou, Dimitrios V. Moysidis, Stefanos Despotopoulos, Amalia Baroutidou, Diamantis Kosmidis, Athanasios Koutsakis, Sotiria Liori, Sotiria Apostolopoulou, Alexandra Frogoudaki, Afrodite Tzifa, Apostolos Galatas, Georgios Source Type: research